摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-丁基-3-(4-氯苯基)脲 | 6333-41-1

中文名称
1-丁基-3-(4-氯苯基)脲
中文别名
——
英文名称
N-butyl-N’-(4-chlorophenyl)urea
英文别名
N-butyl-N'-(4-chlorophenyl)urea;1-butyl-3-(4-chlorophenyl)urea;N-Butyl-N'-(4-chlor-phenyl)-harnstoff;1-n-butyl,3-(4-chlorobenzene)-urea
1-丁基-3-(4-氯苯基)脲化学式
CAS
6333-41-1
化学式
C11H15ClN2O
mdl
MFCD00018554
分子量
226.706
InChiKey
MNOHIZOFLRRKSB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    171-172 °C
  • 沸点:
    313.8±34.0 °C(Predicted)
  • 密度:
    1.175±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.8
  • 重原子数:
    15
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.363
  • 拓扑面积:
    41.1
  • 氢给体数:
    2
  • 氢受体数:
    1

安全信息

  • 海关编码:
    2924299090

SDS

SDS:7595135fd8eb213cda87c7ddd5a9a441
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-丁基-3-(4-氯苯基)脲四(三苯基膦)钯三乙胺三苯基膦二溴三苯基膦 作用下, 以 四氢呋喃二氯甲烷 为溶剂, 反应 13.0h, 生成 [3-Butyl-4-vinyl-oxazolidin-(2Z)-ylidene]-(4-chloro-phenyl)-amine
    参考文献:
    名称:
    Highly Enantioselective Synthesis of 1,3-Oxazolidin-2-imine Derivatives by Asymmetric Cycloaddition Reactions of Vinyloxiranes with Unsymmetrical Carbodiimides Catalyzed by Palladium(0) Complexes
    摘要:
    4-Vinyl-1,3-oxazoilidin-2-imine derivatives have been synthesized by cycloaddition reactions of 2-vinyloxiranes with unsymmetrical carbodiimides catalyzed by palladium(0) complexes-in excellent total isolated yields. After reaction two compounds were always formed, one of which was isolated as the major product. A bulky alkyl group on one of the nitrogen atoms of the carbodiimide enhanced the product ratio in favor of the N-aryl-3-alkyl-1,3-oxazolidin-2-imine. Highly enantioselective cycloadducts (up to >99% ee) were formed by using TolBINAP as the chiral phosphine ligand, in THF at ambient temperatures. The enantiodetermination is believed to be dependent on nucleophilic attack of the anionic nitrogen of the carbodiimide due to the steric interaction of the carbodiimide substituents with the chiral phosphine ligand.
    DOI:
    10.1021/jo9804341
  • 作为产物:
    参考文献:
    名称:
    实用的合成氨酰胺肟的Tiemann重排的N-取代的氰胺。
    摘要:
    通过用苯磺酰氯(TsCl或邻-NsCl)和DIPEA进行mid胺肟的Tiemann重排,可以轻松而通用地合成各种N-取代的氰胺。
    DOI:
    10.1021/ol403645y
点击查看最新优质反应信息

文献信息

  • Synthesis and Application of a New Fluorous-Tagged Ammonia Equivalent
    作者:Simon D. Nielsen、Garrick Smith、Mikael Begtrup、Jesper L. Kristensen
    DOI:10.1002/chem.200903178
    日期:2010.4.19
    A novel fluorous‐tagged ammonia equivalent has been developed. It is based on a nitrogen–oxygen bond, which can be cleaved in a traceless manner by a molybdenum complex or samarium diiodide. The application in the synthesis of ureas, amides, sulfonamides, and carbamates is described. The scope of the fluorous NO linker is exemplified by the synthesis of itopride, a drug used for the treatment of functional
    已经开发出一种新型的含氟标签的氨当量。它基于氮-氧键,可以通过钼络合物或二碘化sa无痕地裂解。描述了在合成脲,酰胺,磺酰胺和氨基甲酸酯中的应用。氟氮原子连接基团的范围以伊托必利的合成为例,伊托必利是一种用于治疗功能性消化不良的药物。借助于氟纯化方法合成了伊托必利,并以良好的总收率和高纯度分离了产物。
  • Lanthanum(III) Trifluoromethanesulfonate Catalyzed Direct Synthesis of Ureas from N-Benzyloxycarbonyl-, N-Allyloxycarbonyl-, and N-2,2,2-Trichloroethoxycarbonyl-Protected Amines
    作者:Hee-Kwon Kim、Tien Tan Bui
    DOI:10.1055/s-0040-1707991
    日期:2020.6
    A novel lanthanum triflate mediated conversion of N-benzyl­oxycarbonyl-, N-allyloxycarbonyl-, and N-trichloroethoxycarbonyl-­protected amines into nonsymmetric ureas was discovered. In this study, lanthanum triflate was found to be an effective catalyst for preparing various nonsymmetric ureas from protected amines. A variety of protected aromatic and aliphatic carbamates reacted readily with various
    发现了一种新型三氟甲磺酸镧介导的 N-苄氧羰基-、N-烯丙氧羰基-和 N-三氯乙氧羰基-保护的胺转化为非对称脲。在这项研究中,发现三氟甲磺酸镧是一种从受保护的胺制备各种非对称脲的有效催化剂。在三氟甲磺酸镧存在下,各种受保护的芳香族和脂肪族氨基甲酸酯很容易与各种胺反应,以高产率生成所需的尿素。该结果表明,这种由 Cbz、Alloc 和 Troc 氨基甲酸酯催化制备尿素的新型三氟甲磺酸镧可用于形成各种尿素结构。
  • Efficient Direct Halogenation of Unsymmetrical N-Benzyl- and N-Phenylureas with Trihaloisocyanuric Acids
    作者:Lúcia de Aguiar、Marcio de Mattos、Carlos Sanabria、Bruno Costa、Gil Viana
    DOI:10.1055/s-0036-1589149
    日期:2018.3
    halogenation of N-phenylureas was developed using trihaloisocyanuric acids in acetonitrile at room temperature. This protocol proved to be effective for the construction of N-phenylureas with different patterns of substitution. Additionally, less reactive N-benzylureas were halogenated in the presence of a mixture of trifluoroacetic acid and acetonitrile at room temperature. A simple and efficient methodology
    摘要 在室温下,使用三卤异氰尿酸在乙腈中开发了一种简单有效的方法,用于直接卤化N-苯基脲。该方案被证明对于构建具有不同取代模式的N-苯基脲是有效的。另外,在室温下,在三氟乙酸和乙腈的混合物存在下,将反应性较低的N-苄基脲卤化。 在室温下,使用三卤异氰尿酸在乙腈中开发了一种简单有效的方法,用于直接卤化N-苯基脲。该方案被证明对于构建具有不同取代模式的N-苯基脲是有效的。另外,在室温下,在三氟乙酸和乙腈的混合物存在下,将反应性较低的N-苄基脲卤化。
  • Process for the preparation of phenyl ureas
    申请人:SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V.
    公开号:EP0319111A2
    公开(公告)日:1989-06-07
    A process for the preparation of phenyl ureas, which comprises reacting a nitrobenzene with an amine and carbon monoxide at an elevated temperature in the presence of a palladium catalyst, the amine being supplied continuously or stepwise during the period of the reaction.
    一种制备苯基脲的工艺,包括在钯催化剂存在下,在高温下使硝基苯与胺和一氧化碳反应,胺在反应期间连续或分步供给。
  • NITROGENEOUS TRICYCLIC COMPOUND
    申请人:Asahi Kasei Pharma Corporation
    公开号:EP1829876A1
    公开(公告)日:2007-09-05
    A novel compound represented by the following formula (1) or a salt thereof [wherein R1, R5, R6, R7, and R8 represent hydrogen atom, a halogen atom, hydroxyl group, an alkyl group, an alkenyl group and the like; X1···X2 represents -CH(R2)-CH(R3)-, -CH(R2)-CH(R3)-CH(R4)-, -C(R2)=C(R3)-, or -C(R2)=C(R3)-CH(R4)- (R2, R3, and R4 represent hydrogen atom, or an alkyl group); A1, A11, A2, and A21 represent hydrogen atom, or an alkyl group; Y represents -CH(A3)-, -CH(A3)-C(A4)(A41)-, -CH(A3)-C(A4)(A41)-C(A5)(A51)-, or a single bond (A3, A4, A41, A5, and A51 represent hydrogen atom, or an alkyl group), and Z represents hydroxyl group, or -N(A6)(A61) (As represents hydrogen atom, or an alkyl group, and A61 represents hydrogen atom, an alkyl group, a substituted alkyl group and the like)], having an action of potently inhibiting phosphorylation of myosin regulatory light chain.
    由下式(1)代表的新型化合物或其盐[其中R1、R5、R6、R7和R8代表氢原子、卤素原子、羟基、烷基、烯基等;X1---X2代表-CH(R2)-CH(R3)-、-CH(R2)-CH(R3)-CH(R4)-、-C(R2)=C(R3)-或-C(R2)=C(R3)-CH(R4)-(R2、R3和R4代表氢原子或烷基);A1、A11、A2和A21代表氢原子或烷基;Y 代表 -CH(A3)-、-CH(A3)-C(A4)(A41)-、-CH(A3)-C(A4)(A41)-C(A5)(A51)- 或单键(A3、A4、A41、A5 和 A51 代表氢原子或烷基),Z 代表羟基或 -N(A6)(A61) (As 代表氢原子、或烷基,A61 代表氢原子、烷基、取代的烷基等)],具有有效抑制肌球蛋白调节轻链磷酸化的作用。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐